Cognitive Decline Is a Key Indicator of Lifespan in Alzheimer’s Disease

Click here to view original web page at Cognitive Decline Is a Key Indicator of Lifespan in Alzheimer’s Disease

Cognitive decline is the biggest factor in determining how long patients with Alzheimer’s disease will live after being diagnosed, according to a new study from researchers at UT Southwestern. The findings , published in the Journal of Alzheimer’s Disease, are a first step that could help health care providers […]

Women in Science Day: UVA scientists researching Alzheimer’s Disease

Click here to view original web page at Women in Science Day: UVA scientists researching Alzheimer’s Disease

CHARLOTTESVILLE, Va. (CBS19 NEWS) — Women in Science Day was celebrated internationally on Friday, and women in STEM are leading the way to life-saving research at the University of Virginia. Hannah Ennerfelt entered college not knowing she’d leave as a scientist. It wasn’t until she stepped foot in a […]

Women in Science Day: UVA scientists researching Alzheimer’s Disease

Click here to view original web page at Women in Science Day: UVA scientists researching Alzheimer’s Disease

CHARLOTTESVILLE, Va. (CBS19 NEWS) — Women in Science Day was celebrated internationally on Friday, and women in STEM are leading the way to life-saving research at the University of Virginia. Hannah Ennerfelt entered college not knowing she’d leave as a scientist. It wasn’t until she stepped foot in a […]

Cognetivity Neurosciences presents at Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2021

Click here to view original web page at Cognetivity Neurosciences presents at Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2021

New results presented at leading conference on Alzheimer’s therapeutic trials provide key evidence supporting use of Cognetivity’s platform to streamline delivery of breakthrough disease-modifying drugs to appropriate patients VANCOUVER, BC, Nov. 9, 2021 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN) (OTCQB: CGNSF) (FWB: 1UB) has […]

Oligomerix Presents Data on Lead Program at Clinical Trials on Alzheimer’s Disease (CTAD) Conference and Society for Neuroscience Meeting

Click here to view original web page at Oligomerix Presents Data on Lead Program at Clinical Trials on Alzheimer’s Disease (CTAD) Conference and Society for Neuroscience Meeting

— Phase 1 trial for oral, small molecule therapeutic targeting tau planned to begin 2Q22 — WHITE PLAINS, N.Y., November 09, 2021 –( BUSINESS WIRE )–Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for Alzheimer’s and rare neurodegenerative diseases, announced that the […]

Morning Pointe Foundation To Present Virtual Seminar On Sleep Related To Aging and Alzheimer’s Disease

Click here to view original web page at Morning Pointe Foundation To Present Virtual Seminar On Sleep Related To Aging and Alzheimer’s Disease

Dr. Lauren Whitehurst, assistant professor of Cognitive Neuroscience, University of Kentucky The Morning Pointe Foundation, together with Dr. Lauren N. Whitehurst, Ph.D., assistant professor at the University of Kentucky specializing in cognitive neuroscience, will present “Getting a Good Night’s Rest: Sleep Implications for Healthy Aging,” a virtual Caregiver Café […]

Alzheimer’s Disease & the Endocannabinoid System

Click here to view original web page at Alzheimer’s Disease & the Endocannabinoid System

Many parallels exist between cannabis and psychedelics. Among them are the diverse therapeutic effects for which both classes of drugs are now being investigated, from fighting pain and inflammation to aiding treatment of some psychiatric disorders. Also on the list: Alzheimer’s Disease, the most common neurodegenerative disease with as […]

Antioxidant Imbalance Is Early Indicator of Alzheimer’s Disease

Click here to view original web page at Antioxidant Imbalance Is Early Indicator of Alzheimer’s Disease

INRS Professor Charles Ramassamy, specialist on Alzheimer’s disease, doctoral student Mohamed Raâfet Ben Khedher and postdoctoral student Mohamed Haddad. Credit: INRS Research conducted by the Ph.D student Mohamed Raâfet Ben Khedher and the postdoctoral researcher Mohamed Haddad of the Institut national de la recherche scientifique (INRS) has shown that […]

Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer’s Disease

Click here to view original web page at Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer’s Disease

BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Today, the results of a recent pilot clinical trial, funded by neurotech company Actipulse Neuroscience , have demonstrated that its non-invasive intervention devices, using Fast Gamma Magnetic Stimulation (FGMS), can be safely administered to patients with mild Alzheimer’s disease. Actipulse Neuroscience’s proprietary […]

Morning Pointe Foundation To Present Virtual Seminar On Sleep Related To Aging And Alzheimer’s Disease

Click here to view original web page at Morning Pointe Foundation To Present Virtual Seminar On Sleep Related To Aging And Alzheimer’s Disease

The Morning Pointe Foundation, together with Dr. Lauren N. Whitehurst, Ph.D., assistant professor at the University of Kentucky, specializing in cognitive neuroscience, will present “Getting a Good Night’s Rest: Sleep Implications for Healthy Aging,” a virtual Caregiver Café seminar and live question and answer period about the latest research […]